| Infliximab associated with faster symptom resolution compared with corticosteroids alone for the management of immune-related enterocolitis DH Johnson, CM Zobniw, VA Trinh, J Ma, RL Bassett, N Abdel-Wahab, ... Journal for immunotherapy of cancer 6, 1-8, 2018 | 145 | 2018 |
| Characteristics and clinical significance of cytogenetic abnormalities in polycythemia vera G Tang, JEH Lopez, SA Wang, S Hu, J Ma, S Pierce, W Zuo, ... Haematologica 102 (9), 1511, 2017 | 55 | 2017 |
| Phase II clinical trial of pembrolizumab in patients with progressive metastatic pheochromocytomas and paragangliomas C Jimenez, V Subbiah, B Stephen, J Ma, D Milton, M Xu, A Zarifa, ... Cancers 12 (8), 2307, 2020 | 52 | 2020 |
| Atypical plant homeodomain of UBR7 functions as an H2BK120Ub ligase and breast tumor suppressor S Adhikary, D Chakravarti, C Terranova, I Sengupta, M Maitituoheti, ... Nature communications 10 (1), 1398, 2019 | 44 | 2019 |
| Adjuvant versus neoadjuvant chemotherapy in triple-negative breast cancer patients with BRCA mutations K Clifton, A Gutierrez-Barrera, J Ma, R Bassett, J Litton, H Kuerer, ... Breast cancer research and treatment 170, 101-109, 2018 | 39 | 2018 |
| Clonal hematopoiesis is associated with increased risk of severe neurotoxicity in axicabtagene ciloleucel therapy of large B-cell lymphoma NY Saini, DM Swoboda, U Greenbaum, J Ma, RD Patel, K Devashish, ... Blood cancer discovery 3 (5), 385-393, 2022 | 36 | 2022 |
| Statistical methods for establishing personalized treatment rules in oncology J Ma, BP Hobbs, FC Stingo BioMed research international 2015, 2015 | 35 | 2015 |
| PD‐L1 detection in histology specimens and matched pleural fluid cell blocks of patients with NSCLC HB Grosu, A Arriola, J Stewart, J Ma, R Bassett, M Hernandez, D Ost, ... Respirology 24 (12), 1198-1203, 2019 | 34 | 2019 |
| Expression of programmed death ligand 1 (PD-L1) in posttreatment primary inflammatory breast cancers and clinical implications J He, L Huo, J Ma, J Zhao, RL Bassett, X Sun, NT Ueno, B Lim, Y Gong American journal of clinical pathology 149 (3), 253-261, 2018 | 24 | 2018 |
| Continuous time Markov chain approaches for analyzing transtheoretical models of health behavioral change: A case study and comparison of model estimations J Ma, W Chan, BC Tilley Statistical methods in medical research 27 (2), 593-607, 2018 | 23 | 2018 |
| High expression of PD-1 and PD-L1 in ocular adnexal sebaceous carcinoma TJ Kandl, O Sagiv, JL Curry, J Ning, J Ma, CW Hudgens, J Van Arnam, ... Oncoimmunology 7 (9), e1475874, 2018 | 22 | 2018 |
| Predicting lymph node metastasis in non-small cell lung cancer: prospective external and temporal validation of the HAL and HOMER models G Martinez-Zayas, FA Almeida, L Yarmus, D Steinfort, DR Lazarus, ... Chest 160 (3), 1108-1120, 2021 | 18 | 2021 |
| Feasibility of fine‐needle aspiration for assessing responses to chemotherapy in metastatic nodes marked with clips in breast cancer: A prospective registry study AS Caudle, HM Kuerer, S Krishnamurthy, K Shin, BP Hobbs, J Ma, ... Cancer 125 (3), 365-373, 2019 | 18 | 2019 |
| Phase II trial of high-dose gemcitabine/busulfan/melphalan with autologous stem cell transplantation for primary refractory or poor-risk relapsed Hodgkin lymphoma Y Nieto, PF Thall, J Ma, BC Valdez, S Ahmed, P Anderlini, U Popat, ... Biology of Blood and Marrow Transplantation 24 (8), 1602-1609, 2018 | 17 | 2018 |
| Analysis of transtheoretical model of health behavioral changes in a nutrition intervention study—a continuous time Markov chain model with Bayesian approach J Ma, W Chan, CL Tsai, M Xiong, BC Tilley Statistics in Medicine 34 (27), 3577-3589, 2015 | 17 | 2015 |
| Bayesian predictive modeling for genomic based personalized treatment selection J Ma, FC Stingo, BP Hobbs Biometrics 72 (2), 575-583, 2016 | 15 | 2016 |
| A multi-arm phase Ib/II study designed for rapid, parallel evaluation of novel immunotherapy combinations in relapsed/refractory acute myeloid leukemia NJ Short, G Borthakur, N Pemmaraju, CD Dinardo, TM Kadia, E Jabbour, ... Leukemia & Lymphoma 63 (9), 2161-2170, 2022 | 13 | 2022 |
| Incidence, patterns of progression, and outcomes of preexisting and newly discovered brain metastases during treatment with anti–PD‐1 in patients with metastatic melanoma G Schvartsman, J Ma, RL Bassett Jr, LE Haydu, RN Amaria, P Hwu, ... Cancer 125 (23), 4193-4202, 2019 | 13 | 2019 |
| Pheochromocytoma: a clinicopathologic and molecular study of 390 cases from a single center Z Liu, J Ma, C Jimenez, M Zhang The American Journal of Surgical Pathology 45 (9), 1155-1165, 2021 | 12 | 2021 |
| ONC201 Shows Potent Anticancer Activity Against Medullary Thyroid Cancer via Transcriptional Inhibition of RET, VEGFR2, and IGFBP2 R Bagheri-Yarmand, R Dadu, L Ye, Y Shiny Jebaraj, JA Martinez, J Ma, ... Molecular cancer therapeutics 20 (4), 665-675, 2021 | 12 | 2021 |
